share_log

賽生藥業：根據《收購守則》規則22作出的交易披露

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Hong Kong Stock Exchange ·  Apr 18 04:38
Summary by Moomoo AI
赛生药业於2024年4月17日披露，公司執行人員趙宏根據香港《公司收購及合併守則》規則22進行了一宗證券交易。該交易涉及透過協議安排進行的私有化，趙宏於2024年4月5日買入300,000股股份，每股價格為$0.0000，交易後持股數目為12,779,690股。其中，Convergence International Holdings Ltd.持有11,979,690股，趙宏個人持有800,000股。此次股份獎勵是根據公司採納的首次公開發售後受限股份單位計劃。交易完成後，趙宏所持股份佔該類別證券的百分比為2.0356%。
赛生药业於2024年4月17日披露，公司執行人員趙宏根據香港《公司收購及合併守則》規則22進行了一宗證券交易。該交易涉及透過協議安排進行的私有化，趙宏於2024年4月5日買入300,000股股份，每股價格為$0.0000，交易後持股數目為12,779,690股。其中，Convergence International Holdings Ltd.持有11,979,690股，趙宏個人持有800,000股。此次股份獎勵是根據公司採納的首次公開發售後受限股份單位計劃。交易完成後，趙宏所持股份佔該類別證券的百分比為2.0356%。
SAI PHARMACEUTICALS DISCLOSED ON 17 APRIL 2024 THAT ITS EXECUTIVE OFFICER ZHAO HUNG CONDUCTED A SECURITIES TRANSACTION UNDER RULE 22 OF THE HONG KONG CODE OF COMPANIES ACQUISITIONS AND MERGERS. The transaction involves the privatization by arrangement of agreements. On April 5, 2024, Zhao Hong purchased 300,000 shares at a price of $0.0000 per share and a post-transaction holding of 12,779,690 shares. Of these, Convergence International Holdings Ltd. holds 11,979,690 shares and Zhao Hong personally holds 800,000 shares. This share award is based on the limited share unit plan adopted by the Company following its initial public offering. At the close of the transaction, Zhao Hong's shares accounted for 2.0356% of the securities in the class.
SAI PHARMACEUTICALS DISCLOSED ON 17 APRIL 2024 THAT ITS EXECUTIVE OFFICER ZHAO HUNG CONDUCTED A SECURITIES TRANSACTION UNDER RULE 22 OF THE HONG KONG CODE OF COMPANIES ACQUISITIONS AND MERGERS. The transaction involves the privatization by arrangement of agreements. On April 5, 2024, Zhao Hong purchased 300,000 shares at a price of $0.0000 per share and a post-transaction holding of 12,779,690 shares. Of these, Convergence International Holdings Ltd. holds 11,979,690 shares and Zhao Hong personally holds 800,000 shares. This share award is based on the limited share unit plan adopted by the Company following its initial public offering. At the close of the transaction, Zhao Hong's shares accounted for 2.0356% of the securities in the class.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more